602655 Disclosed is the use of an active substance known from human medicine for the treatment of gout in the preparation of a medicament for the treatment of laminitis, laminitis associated pain and/or laminitis-associated inflammation in equids (horses), wherein the medicament contains at least prednisolone and/or prednisone as an active substance.